bisbenzimidazole has been researched along with Celiac Disease in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Celiac Disease: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervio, E | 1 |
| Volta, U | 1 |
| Verri, M | 1 |
| Boschi, F | 1 |
| Pastoris, O | 1 |
| Granito, A | 1 |
| Barbara, G | 1 |
| Parisi, C | 1 |
| Felicani, C | 1 |
| Tonini, M | 1 |
| De Giorgio, R | 1 |
1 other study available for bisbenzimidazole and Celiac Disease
| Article | Year |
|---|---|
Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro.
Topics: Adult; Apoptosis; Apoptotic Protease-Activating Factor 1; bcl-2-Associated X Protein; Bisbenzimidazo | 2007 |